# Avocado Soybean Unsaponifiables Osteoarthritis Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/avocado-soybean-unsaponifiables-osteoarthritis-meta-analysis-evidence-review
Category: evidence-review
Summary: Avocado Soybean Unsaponifiables Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources i
Last reviewed: 2026-08-20
Reviewed by: Migaku Evidence Review
# Avocado Soybean Unsaponifiables Osteoarthritis Meta-analysis: What the Evidence Says

## Quick Answer

Avocado Soybean Unsaponifiables Osteoarthritis Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Using Dose–Response Correlation Re-Analyzing to Distinguish Placebo from Standardized Rose-Hip Powder (Lito) in a Clinical Trial on Osteoarthritis Where Data Initially Looked Identical | randomized trial | 2 | 2026-01-20 | 10.3390/nu18020331 |
| Avocado–Soybean Unsaponifiables Enhance Tendon Healing via Anti-Inflammatory and Antioxidant Mechanisms in a Rat Achilles Injury Model | preclinical study | 4 | 2025-11-14 | 10.3390/medicina61112035 |

## What The Sources Report

- Rosa-canina 1 2 3 Osteoarthritis (OA) is a progressive degenerative joint disease associated with chronic pain, stiffness, functional limitations, and reduced quality of life. [Motawei Alzahraa Mahmoud (2026); evidence level 2]
- If an intervention exerts pharmacologic effects, greater dose/kg should be associated with greater improvement. [Motawei Alzahraa Mahmoud (2026); evidence level 2]
- Tendon injuries are common musculoskeletal disorders that result in pain, disability, and functional loss. [Dinç Mustafa (2025); evidence level 4]
- However, this regenerative process is often inefficient and may result in fibrosis, disorganized collagen deposition, adhesion formation, or incomplete mechanical restoration. [Dinç Mustafa (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For avocado soybean unsaponifiables osteoarthritis meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Motawei Alzahraa Mahmoud (2026). Using Dose–Response Correlation Re-Analyzing to Distinguish Placebo from Standardized Rose-Hip Powder (Lito) in a Clinical Trial on Osteoarthritis Where Data Initially Looked Identical. DOI: 10.3390/nu18020331. PMCID: PMC12845314. PMID: 41599942. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12845314/
- Dinç Mustafa (2025). Avocado–Soybean Unsaponifiables Enhance Tendon Healing via Anti-Inflammatory and Antioxidant Mechanisms in a Rat Achilles Injury Model. DOI: 10.3390/medicina61112035. PMCID: PMC12654124. PMID: 41303871. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12654124/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.